US Markets for Contrast Agents and Radiopharmaceuticals 2007

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US CONTRAST AGENT AND RADIOPHARMACEUTICAL MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Market Definition
  • 1.2.2 Procedures
    • 1.2.2.1 Radiopharmaceutical Procedures
    • 1.2.2.2 CT and X-Ray Contrast-Enhanced Procedures
    • 1.2.2.3 Contrast-Enhanced MRI Procedures
  • 1.2.3 Market Forecast
    • 1.2.3.1 Radiopharmaceutical Market
    • 1.2.3.2 CT and X-Ray Contrast Agent Market
    • 1.2.3.3 MRI Contrast Agent Market
    • 1.2.3.4 Ultrasound Contrast Agent Market
    • 1.2.3.5 Power Injector Market
  • 1.2.4 Market Drivers and Limiters
    • 1.2.4.1 Market Drivers
    • 1.2.4.2 Market Limiters
• 1.3 Competitive Analysis

2.0 RADIOPHARMACEUTICAL MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Market Definition
  • 2.2.2 Procedures
  • 2.2.3 Market Forecast
    • 2.2.3.1 SPECT Radiopharmaceutical Market
    • 2.2.3.2 PET Radiopharmaceutical Market
    • 2.2.3.3 Installed Base
  • 2.2.4 Market Drivers and Limiters
    • 2.2.4.1 Market Drivers
    • 2.2.4.2 Market Limiters
• 2.3 Competitive Analysis

3.0 CT AND X-RAY CONTRAST AGENT MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Market Definition
  • 3.2.2 Procedures
  • 3.2.3 Market Forecast
    • 3.2.3.1 CT Contrast Agent Market
    • 3.2.3.2 Cardiovascular X-Ray Contrast Agent Market
    • 3.2.3.3 Conventional X-Ray Contrast Agent Market
    • 3.2.3.4 CT Installed Base
    • 3.2.3.5 Fixed Cardiovascular C-Arm Systems Installed Base
  • 3.2.4 Market Drivers and Limiters
    • 3.2.4.1 Market Drivers
    • 3.2.4.2 Market Limiters
• 3.3 Competitive Analysis

4.0 MRI CONTRAST AGENT MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Market Definition
  • 4.2.2 Procedures
  • 4.2.3 Market Forecast
    • 4.2.3.1 Hospital MRI Contrast Agent Market
    • 4.2.3.2 Nonhospital MRI Contrast Agent Market
    • 4.2.3.3 Installed Base
• 4.2.4 Market Drivers and Limiters
  • 4.2.4.1 Market Drivers
  • 4.2.4.2 Market Limiters
• 4.3 Competitive Analysis

5.0 ULTRASOUND CONTRAST AGENT MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Market Definition
  • 5.2.2 Procedures
  • 5.2.3 Market Forecast
    • 5.2.3.1 Installed Base
  • 5.2.4 Market Drivers and Limiters
    • 5.2.4.1 Market Drivers
    • 5.2.4.2 Market Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Emerging Competitors

6.0 POWER INJECTOR MARKET

• 6.1 Market Overview
• 6.2 Market Analysis
  • 6.2.1 Market Definition
  • 6.2.2 Procedures
  • 6.2.3 Market Forecast
    • 6.2.3.1 CT Power Injector Market
    • 6.2.3.2 MRI Power Injector Market
    • 6.2.3.3 Installed Base
  • 6.2.4 Market Drivers and Limiters
    • 6.2.4.1 Market Drivers
    • 6.2.4.2 Market Limiters
• 6.3 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: Contrast Agents and Radiopharmaceutical Market, by Segment, US (US$), 2006-2012
• Exhibit 2: Radiopharmaceutical Market, by Segment, US (US$), 2006-2012
• Exhibit 3: CT and X-Ray Contrast Agent Market, by Segment, US (US$), 2006-2012
• Exhibit 4: MRI Contrast Agent Market, US (US$), 2006-2012
• Exhibit 5: Ultrasound Contrast Agent Market, US (US$), 2006-2012
• Exhibit 6: Power Injector Market, by Segment, US (US$), 2006-2012
• Exhibit 7: Leading Competitors in the Contrast Agent and Radiopharmaceutical Market, US, 2007

METHODOLOGY

CHAPTER 1: US CONTRAST AGENT AND RADIOPHARMACEUTICAL MARKET

• Exhibit 8: Contrast Agent and Radiopharmaceutical Market, US (US$), 2006-2012
• Exhibit 9: Radiopharmaceutical Procedures, by Segment US, 2006-2012 (Graphical Format)
• Exhibit 10: Radiopharmaceutical Procedures, by Segment US, 2006-2012 (Tabular Format)
• Exhibit 11: Contrast-Enhanced CT and X-Ray Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 12: Contrast-Enhanced CT and X-Ray Procedures, by Segment, US, 2006-2012 (Tabular Format)
• Exhibit 13: Contrast-Enhanced MRI Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 14: Contrast-Enhanced MRI Procedures, by Segment, US, 2006-2012 (Tabular Format)
• Exhibit 15: Contrast Agent and Radiopharmaceutical Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 16: Contrast Agent and Radiopharmaceutical Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 17: Contrast Agent and Radiopharmaceutical Market Growth, by Segment, US, 2007-2012
• Exhibit 18: Drivers and Limiters of the Contrast Agent and Radiopharmaceutical Market, US
• Exhibit 19: Leading Competitors in Contrast Agent and Radiopharmaceutical Market, as a % of Total, US, 2007

CHAPTER 2: RADIOPHARMACEUTICAL MARKET

• Exhibit 20: Radiopharmaceutical Market, US (US$), 2006-2012
• Exhibit 21: Radiopharmaceutical Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 22: Radiopharmaceutical Procedures, by Segment, US, 2006-2012 (Tabular Format)
• Exhibit 23: SPECT Procedures, US, 2006-2012 (Graphical Format)
• Exhibit 24: PET Procedures, US, 2006-2012 (Graphical Format)
• Exhibit 25: Radiopharmaceutical Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 26: Radiopharmaceutical Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 27: SPECT Radiopharmaceutical Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 28: SPECT Radiopharmaceutical Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 29: PET Radiopharmaceutical Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 30: PET Radiopharmaceutical Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 31: Nuclear Medicine System Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 32: Nuclear Medicine Systems Installed Base, US, 2006-2012 (Tabular Format)
• Exhibit 33: Drivers and Limiters of the Radiopharmaceutical Market, US
• Exhibit 34: Leading Competitors in Radiopharmaceutical Market, as a % of Total, US, 2007 (Graphical Format)
• Exhibit 35: Leading Competitors in Radiopharmaceutical Market, by Segment, as a % of Total, US, 2007 (Tabular Format)
• Exhibit 36: Leading Competitors in SPECT Radiopharmaceutical Market, as a % of Total, US, 2007 (Graphical Format)
• Exhibit 37: Leading Competitors in PET Radiopharmaceutical Market, as a % of Total, US, 2007 (Graphical Format)

CHAPTER 3: CT AND X-RAY CONTRAST AGENT MARKET

• Exhibit 38: CT and X-Ray Contrast Agent Market, US (US$), 2006-2012
• Exhibit 39: Contrast-Enhanced CT and X-Ray Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 40: Contrast-Enhanced CT and X-Ray Procedures, by Segment, US, 2006-2012 (Tabular Format)
• Exhibit 41: CT and X-ray Contrast Agent Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 42: CT and X-ray Contrast Agent Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 43: CT Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 44: CT Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 45: Cardiovascular X-Ray Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 46: Cardiovascular X-ray Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 47: Conventional X-Ray Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 48: Conventional X-Ray Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 49: CT System Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 50: CT System Installed Base, US, 2006-2012 (Tabular Format)
• Exhibit 51: Fixed Cardiovascular C-Arm Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 52: Fixed C-Arm Installed Base, US, 2006-2012
• Exhibit 53: Drivers and Limiters of the CT and X-Ray Contrast Agent Market, US
• Exhibit 54: Leading Competitors in the CT and X-ray Contrast Agent Market, as a % of Total, US, 2007 (Graphical Format)
• Exhibit 55: Leading Competitors in the CT and X-Ray Contrast Agent Market, as a % of Total, US, 2007 (Tabular Format)

CHAPTER 4: MRI CONTRAST AGENT MARKET

• Exhibit 56: MRI Contrast Agent Market, US (US$), 2006-2012
• Exhibit 57: MRI Contrast-Enhanced Procedures, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 58: MRI Contrast-Enhanced Procedures, by Segment US, 2006-2012 (Tabular Format)
• Exhibit 59: MRI Contrast Agent Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 60: MRI Contrast Agent Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 61: Hospital MRI Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 62: Hospital MRI Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 63: Nonhospital MRI Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 64: Nonhospital MRI Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 65: MRI System Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 66: MRI System Installed Base, US, 2006-2012 (Tabular Format)
• Exhibit 67: Drivers and Limiters of the MRI Contrast Agent Market, US
• Exhibit 68: Leading Competitors in MRI Contrast Agent Market, as a % of Total, US, 2007 (Graphical Format)
• Exhibit 69: Leading Competitors in MRI Contrast Agent Market, as a % of Total, US, 2007 (Tabular Format)

CHAPTER 5: ULTRASOUND CONTRAST AGENT MARKET

• Exhibit 70: Ultrasound Contrast Agent Market, US (US$), 2006-2012
• Exhibit 71: Ultrasound Contrast Agent Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 72: Ultrasound Contrast Agent Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 73: Ultrasound System Installed Base, US, 2006-2012 (Graphical Format)
• Exhibit 74: Ultrasound System Installed Base, US, 2006-2012 (Tabular Format)
• Exhibit 75: Drivers and Limiters of the Ultrasound Contrast Agent Market, US
• Exhibit 76: Leading Competitors in Ultrasound Contrast Agent Market as a % of Total, US, 2007 (Graphical Format)

CHAPTER 6: POWER INJECTOR MARKET

• Exhibit 77: Power Injector Market, US (US$), 2006-2012
• Exhibit 78: Contrast-Enhanced CT Procedures, US, 2006-2012 (Graphical Format)
• Exhibit 79: Contrast-Enhanced CT Procedures, US, 2006-2012 (Tabular Format)
• Exhibit 80: Contrast-Enhanced MRI Procedures, US, 2006-2012 (Graphical Format)
• Exhibit 81: Contrast-Enhanced MRI Procedures, US, 2006-2012 (Tabular Format)
• Exhibit 82: Power Injector Market, by Segment, US (US$), 2006-2012 (Graphical Format)
• Exhibit 83: Power Injector Market, by Segment, US (US$), 2006-2012 (Tabular Format)
• Exhibit 84: CT Power Injector Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 85: CT Power Injector Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 86: MRI Power Injector Market, US (US$), 2006-2012 (Graphical Format)
• Exhibit 87: MRI Power Injector Market, US (US$), 2006-2012 (Tabular Format)
• Exhibit 88: Power Injector Installed Base, by Segment, US, 2006-2012 (Graphical Format)
• Exhibit 89: Power Injector Installed Base, by Segment US, 2006-2012 (Tabular Format)
• Exhibit 90: Drivers and Limiters of the Power Injector Market, US
• Exhibit 91: Leading Competitors in Power Injector Market, as a % of Total, US, 2007
• Exhibit 92: Leading Competitors in Power Injector Market, by Segment, as a % of Total, US, 2007
• Exhibit 93: Leading Competitors in CT Power Injector Market, as a % of Total, US, 2007
• Exhibit 94: Leading Competitors in MRI Power Injector Market, as a % of Total, US, 2007